Hepatic gluconeogenesis is essential for maintenance of whole body glucose homeostasis and glucose supply for mammary lactose synthesis in the dairy cow. Upregulation of the gluconeogenic enzyme pyruvate carboxylase (PC) during the transition period is vital in the adaptation to the greater glucose demands associated with peripartum lactogenesis. The objective of this study was to determine if PC transcription in hepatocytes is regulated by DNA methylation and if treatment with a nonsteroidal anti-inflammatory drug (NSAID) alters methylation of an upstream DNA sequence defined as promoter 1. Dairy cows were left untreated (n = 20), or treated with a NSAID during the first 5 d postcalving (n = 20). Liver was biopsied at d 7 precalving and d 7, 14, and 28 postcalving. Total PC and transcript specific gene expression was quantified using quantitative PCR and DNA methylation of promoter 1 was quantified using bisulfite Sanger sequencing. Expression of PC changed over the transition period, with increased expression postcalving occurring concurrently with increased circulating concentration of nonesterified fatty acids. The DNA methylation percentage was variable at all sites quantified and ranged from 21 to 54% across the 15 CpG dinucleotides within promoter 1. The DNA methylation at wk 1 postcalving, however, was not correlated with gene expression of promoter 1-regulated transcripts and we did not detect an effect of NSAID treatment on DNA methylation or PC gene expression. Our results do not support a role for DNA methylation in regulating promoter 1-driven gene expression of PC at wk 1 postcalving. Further research is required to determine the mechanisms regulating increased PC expression over the transition period.
INTRODUCTION
Hepatic gluconeogenesis is essential for maintenance of whole-body glucose homeostasis and glucose supply to the mammary gland for lactose synthesis in the dairy cow (Drackley et al., 2001 ). The major precursor for gluconeogenesis is propionate, which is derived from microbial fermentation of NSC in the rumen. During the transition from pregnancy into lactation, the demand for glucose increases 3-to 4-fold (Bell, 1995; Reynolds et al., 2003) . Pyruvate carboxylase (PC) plays an essential role in the production of glucose in the liver and its expression is increased during the periparturient period as an adaptation to increased glucose requirements (Greenfield et al., 2000; Velez and Donkin, 2005; White et al., 2011a,b) . Pyruvate carboxylase supplies carbon for gluconeogenesis and oxaloacetate for the tricarboxcylic acid cycle (White, 2015) . Several transcript variants of PC are driven by 3 promoters (Agca et al., 2004; Hazelton et al., 2008) . Increased PC expression during the periparturient period and during feed restriction is the result of increased promoter 1 activity (White et al., 2011a) .
Dairy cows experience a degree of inflammation during early lactation that is linked to lipid mobilization, insulin resistance, and depressed milk production (Bertoni et al., 2008a) . Inflammation can induce changes in DNA methylation in response to oxidative stress and pro-inflammatory cytokines, and inhibition of inflammation can affect DNA methylation of CpG dinucleotides and the expression of DNA methyltransferases (Niwa et al., 2010; Hur et al., 2011; Kominsky et al., 2011) . Methylation of PC promoter DNA in human liver is negatively associated with PC gene expression (Ahrens et al., 2013) . Further, a positive effect of nonsteroidal anti-inflammatory drug (NSAID) treatment on hepatic gluconeogenesis has been reported (Vailati Riboni et al., 2015) . We therefore, hypothesized that bovine PC gene expression is regulated by promoter DNA methylation and that DNA methylation of promoter 1 is positively influenced by NSAID treatment.
MATERIALS AND METHODS

Animals
Six hundred thirty-nine cows (n = 134 primiparous and n = 505 multiparous) calving between July 4 and September 5, 2012, in 2 herds (herd 1: n = 228; herd 2: n = 411) were enrolled. Using a randomized block design, cows were allocated to 1 of 3 treatment groups as they calved: no treatment (control; n = 221), NSAID administered on d 1, 3, and 5 postcalving (early; n = 214), or NSAID administered on d 19, 21, and 23 postcalving (late; n = 204). Detailed methods and production data for the cows used in this study have been published previously (Meier et al., 2014) . A subset of 20 cows from the control group and 20 cows from the early NSAID treatment group were selected for biopsy.
Blood Metabolites
Blood was sampled 7 (±3.3) d precalving, and at 7 (±1.0), 14 (±1.3), and 28 (±2.1) d postcalving. Blood was collected into evacuated blood tubes containing lithium heparin (Vacutainer; Becton, Dickinson and Co., Franklin Lakes, NJ), placed in iced water immediately, and centrifuged (1,500 × g for 12 min at 4°C). Aspirated plasma was stored at −20°C before analysis for nonesterified fatty acids (NEFA). Analyses for NEFA were performed on a Modular P800 analyzer (Roche, Basel, Switzerland) at 37°C by Gribbles Veterinary Pathology Ltd. (Hamilton, New Zealand) and NEFA were measured (mmol/L) by the acyl Co-A synthetase, acyl-CoA oxidase colorimetric method using the NEFA C Kit from Wako Pure Chemical Industries Ltd. (Osaka, Japan). The intra-and interassay coefficients of variation were <5%.
Liver Biopsy
Liver tissue was biopsied 7 d precalving and 7, 14, and 28 d postcalving. Briefly, the skin was shaved and disinfected and the area through the skin and body wall was anesthetized with 7 mL of 2% lignocaine (Lopaine 2%, lignocaine hydrochloride 20 mg/mL, Ethical Agents, South Auckland, New Zealand). A stab incision was made through the skin in the right 11th intercostal space at the level of the greater trochanter, through which a 12-gauge × 20 cm biopsy needle was inserted into the liver and approximately 1 g (wet weight) of liver tissue was collected. Liver samples were snapfrozen in liquid nitrogen and stored at −80°C.
Nucleic Acid Extraction
The DNA and RNA were extracted from liver tissue using the Qiagen All-Prep mini kit Plus (Qiagen GmbH, Hilden, Germany). Briefly, approximately 30 mg of tissue was homogenized using a TissueLyser II (Qiagen) for 2 min with 3 ball bearings of 1/8 inch diameter (Farrell Bearings, Hamilton, NZ) in a tube containing RLT Plus lysis buffer (Qiagen). The DNA was purified using the Qiagen All-prep column and the flow through was used to isolate total RNA using a Qiagen RNeasy column (Qiagen). All RNA samples were DNase treated using the Ambion DNA-free kit (Ambion, Austin, TX) to remove any contaminating DNA as previously described (Grala et al., 2010 (Grala et al., , 2013 Crookenden et al., 2015) . The quantity of DNA and RNA was determined using Qubit fluorometric quantification. The DNA and RNA purity was determined by spectrophotometry using a Nanodrop ND-1000 (Nanodrop Technologies, Wilmington, DE). The DNA integrity was assessed on a 0.8% agarose gel and RNA integrity was assessed with a RNA 6000 Nano LabChip kit using the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). All DNA samples were of high molecular weight (single high molecular weight band) and all RNA samples had an integrity number above 7. Final sample numbers used in gene expression analysis for each time point were as follows: precalving d 7 (±3.2), control: n = 15, NSAID: n = 10; and postcalving d 7 (±1.4), control: n = 19, NSAID: n = 19; d 14 (±1.1), control: n = 18, NSAID: n = 19; and d 28 (±1.7), control: n = 17, NSAID: n = 19. The wk-1 time point was used for DNA methylation analyses. Precalving samples were excluded if they had been taken within 4 d of calving.
cDNA Synthesis
One microgram of each RNA sample (final volume = 20 μL) was used for cDNA synthesis using the Invitrogen Superscript III Supermix kit (Invitrogen Corporation, Carlsbad, CA). Total RNA was transcribed according to the manufacturer's instructions using 27 μM of random pentadecamers. Briefly, RNA and random pentadecamers were mixed and denatured at 65°C for 5 min, followed by 1 min on ice. Annealing buffer and Superscript/RNase was added to samples and incubated for 10 min at 25°C (primer annealing), followed by 50 min at 50°C and 5 min at 85°C to inactivate the enzyme. Reverse transcription controls were performed, whereby the above process was completed without the addition of superscript enzyme. No amplification products were detected for any genes in the reverse transcriptase control samples.
Quantitative Real-Time PCR
Four endogenous control genes were tested for suitability for normalizing gene expression (COX4I1, EIF3K, RPS9, and YWHAZ). Analysis with GeNorm and Normfinder revealed COX4I1 had the most stable expression with a stability value of 0.250 and 0.038, respectively. Normfinder identified RPS9 and COX4I1 as the best combination of 2 genes (0.042 stability value). Analysis with GeNorm did not indicate any increase in stability with the addition of a third endogenous control gene. As a result of this analysis, RPS9 and COX4I1 were chosen as the 2 endogenous control genes for this study. Advanced relative quantification of the PC transcription was analyzed using Roche LightCycler480 software. The PC coding assay quantified all transcript variants. Three calibrator samples were used on all plates to normalize expression over multiple quantitative real time-PCR plates. Additionally, transcript-specific expression of PC variants (D, E, and F) was determined using assays developed by White et al., 2011b (Table 1 ; Supplemental Figure S1 , http://dx.doi.org/10.3168/jds.2015-10331). Promoter 1 of PC regulates expression of transcripts A, B, C, and F, promoter 2 regulates expression of transcript D, and promoter 3 regulates expression of transcript E. Total promoter 1 transcript expression is calculated as PC coding (all transcripts) minus variants D and E. All primers and probes were synthesized commercially (Integrated DNA Technologies, Singapore).
Bisulfite Conversion and PCR
The DNA was bisulfite converted and purified using the Zymo EZ DNA methylation kit Gold (Zymo, Irvine, CA) per the manufacturer's instructions. Two assays were optimized to amplify the defined promoter 1 region (Table 2 ; Supplemental Figure S1 , http:// dx.doi.org/10.3168/jds.2015-10331). The KAPA HiFi Uracil+ Ready Mix (KAPA Biosystems, Wilmington, MA) was used for amplification per the manufacturer's instructions. Annealing temperatures of 57.4 or 58.2°C were used for assay 1 and 2, respectively. Following (White et al. 2011a ). The PC coding assay targets the coding region of pyruvate carboxylase and amplifies all variants of the gene. Three transcript specific assays were also utilized. One of the promoter 1-regulated transcripts (5 UTR_F) was amplified with the UTR_F assay. The promoter 2-regulated transcript (5 UTR_D), was amplified with UTR_D assay. The promoter 3-regulated transcript (5 UTR_E), was amplified with the UTR_E assay. 5823 amplification, PCR products were sequenced by Sanger sequencing to confirm the correct product was generated and to detect variation in the methylation status.
A-Tailing, Cloning, and Sequencing
A-Tailing of the PCR products was conducted using Roche Taq DNA polymerase before cloning. Briefly, 4 μL of each PCR product was poly-A tailed with 1 μL of 10 × buffer + Mg (Roche Diagnostics), 2 μL of 1 mM dATP, 1 μL of Taq polymerase (Roche Diagnostics), and 2 μL of DNase-free water for 20 min at 72°C. For cloning, 4 μL of fresh A-tailed DNA was ligated into pCR4-TOPO vector (Life Technologies, Carlsbad, CA) using the TOPO TA cloning kit for sequencing (Life Technologies) as per the manufacturer's instructions using 1 μL of salt solution and 1 μL of vector per reaction. Ligated vector was then transformed into Top10 cells (Life Technologies) as per manufacturer's instructions, and the cells plated onto Luria-Bertani agar plates containing ampicillin (50 μg/mL), X-gal (20 μg/ mL), and isopropyl β-d-1-thiogalactopyranoside (100 μM). The following day, 20 white colonies per sample were isolated, placed into Luria-Bertani broth containing ampicillin (50 μg/mL) and incubated on shaking incubators at 180 rpm at 37°C overnight. Plasmid DNA and was then harvested from the cells using MachereyNagel miniprep kits (Bethlehem, PA) as per the manufacturer's instructions. Plasmid DNA was aliquoted into 96-well MLtraFlux semi-skirted ABI-style plates (SSIBIO) and quantified by spectrophotometry using a Nanodrop ND-1000 (Nanodrop Technologies). Plasmid DNA was present in all 20 isolates for most samples. Samples that did not have sufficient plasmid DNA were repeated. The plasmid DNA was then diluted to 100 ng/μL. Applied Biosystems BigDye version 3.1 (Foster City, CA) terminator chemistry was used to generate dye-terminated PCR products for Sanger sequencing. Each reaction consisted of 2 μL of BigDye, 2 μL of M13 −20 forward primer (5 pmol/μL), 3 μL of 5 × buffer, 11 μL of DNase-free water, and 2 μL of plasmid DNA (200 ng) in a 96-well plate. The PCR was performed on Applied Biosystems 9700 Gold Block thermal cyclers with an initial denaturation of 1 min at 96°, followed by 25 cycles of 10 s at 96°C, 5 s at 50°C, and 4 min at 60°C. Dye-terminator removal was performed immediately before sequencing using Agencourt CleanSeq beads (Beckman Coulter, Fullerton, CA) as per the manufacturer's instructions. Briefly, 10 μL of CleanSeq reagent and 60 μL of 85% ethanol were transferred to each well, a foil seal (4titude, Dorking, UK) was placed on the plate, and mixed by inversion. The plate was then placed on a white Agencourt SPRIPlate 96R (Beckman Coulter) for 3 min and the cleared supernatant removed. The beads were washed twice with 100 μL of 85% ethanol and allowed to air dry in the dark. Finally, 40 μL of DNase-free water was added to each well, mixed by pipetting, and placed on a white SPRIPlate 96R for 5 min, and then 28 μL of supernatant was transferred to a fresh 96-well plate. Sanger sequencing was performed on an ABI Prism 3130XL Genetic Analyzer by the Centre of Genomics, Proteomics, and Metabolomics at the School of Biological Sciences, The University of Auckland. Sequence data were analyzed using Geneious R6.1.7 (Biomatters Ltd., Auckland, New Zealand). All samples analyzed had at least 20 DNA isolates that mapped to the promoter region. Any sequencing reactions that failed to produce high-quality sequence were repeated.
Statistical Analysis
The DNA methylation analysis was based on the percentage methylated for each CpG dinucleotide and the percentage methylated across all CpG dinucleotides within each cow. The model used was a one-way ANO-VA for the effect of treatment (control vs. NSAID). The relationship between promoter 1 DNA methylation and gene expression (PC coding and promoter 1-regulated transcripts) was investigated using Pearson correlations between percentage methylation for each dinucleotide and gene expression. Results are presented as Pearson correlation coefficient and P-value. Gene expression and NEFA concentrations were subjected to repeated measures ANOVA using a linear mixed effects model. Group, sample day relative to calving date, and their interactions were included as fixed factors and cow (intercept) as a random factor. All results are presented as least squares means and standard errors of the mean for predetermined times. Significance was declared if P < 0.05.
RESULTS AND DISCUSSION
Promoter 1-Regulated PC Transcripts Increased with the Transition to Lactation
Promoter 1-regulated PC transcripts increased with the transition to lactation coincident with increased demand for glucose for mammary lactose synthesis. Promoter 1-driven transcripts increased 1.5-fold from d 7 precalving to d 7 postcalving, then decreased back to precalving expression by d 28 postcalving (P < 0.05, Figure 1 , Table 3 ). In contrast, promoter 2-and 3-regulated transcripts did not increase immediately postcalving and decreased 1.2-fold at d 28 postcalving (P < 0.05, Table 3 ). Promoter 1-regulated transcripts had a similar profile to NEFA concentrations, with NEFA in- creasing 1.6-fold with the transition to lactation ( Figure  1 ). This is consistent with previous reports that fatty acid concentration increases PC transcript expression, particularly promoter 1-regulated transcripts both in vivo and in vitro (White et al., 2011a) .
The PC expression increases during the periparturient period and during feed restriction to increase hepatic glucose production coincident with decreased intake and increased mobilization of body reserves (Greenfield et al., 2000; Velez and Donkin, 2005; White et al., 2011b) . As requirements for glucose increase with the transition to lactation, body reserves are mobilized and the gluconeogenic capacity of the liver is increased to maintain milk production. The results from this study support the hypothesis that transition cows achieve this through an increase in expression of promoter 1-regulated PC transcripts.
DNA Methylation of PC Was Not Correlated with Gene Expression
The DNA methylation of CpG dinucleotides in promoter 1 of PC was not correlated with PC gene expression at 1 week postcalving (P = 0.83, Table 4 ). Average methylation status across all CpG was 43% and 42% in control and NSAID-treated cows, respectively, and ranged from 20% (CpG 1) to 56% (CpG 5) in control and 21% (CpG 1) to 52% (CpG 5) in treated cows. No correlation was found between average DNA methylation and total PC transcript expression (P = 0.4). Additionally, no correlation was found among DNA methylation at specific CpG sites and total PC transcript expression (P > 0.05).
Promoter 1 drives expression of the main variants of PC that are expressed at wk 1 postcalving. The precise mechanism regulating promoter 1 activity is unknown; Figure 1 . Pyruvate carboxylase (PC) gene expression and nonesterified fatty acids (NEFA) over the transition period. Data are presented as least squares means, and error bars are the standard errors of the mean. Postcalving d 7 was greater than 7 d precalving for NEFA, PC coding, and PC ABCF (P < 0.05). Expression of PC_ABCF was calculated by taking PC coding minus UTR_D (promoter 2-regulated transcript expression) and UTR_E (promoter 3-regulated transcript expression). however, it has been hypothesized that binding of transcription factors that are upregulated in response to metabolic status, such as NEFA concentration, increases promoter 1 activity and transcript expression (White et al., 2011a) . The DNA methylation is generally associated with inhibition of promoter activity, as it can prevent the binding of transcription factors and is associated with an indirect repression of chromatin state, through the recruitment of methyl-CpG-binding proteins (Wolffe and Matzke, 1999) . The DNA methylation may, therefore, prevent binding of transcription factors to promoter 1, so that it is unresponsive to homeorhetic signals. In human liver, PC gene expression is negatively correlated with promoter DNA methylation (Ahrens et al., 2013) . Results presented here, however, do not support a role for DNA methylation of promoter 1 in regulating PC transcript expression during early lactation. However, analysis of other time points may have revealed a role for DNA methylation in regulating the expression of PC within an animal over time. Alternative epigenetic mechanisms, such as histone modification and miRNA transcriptional repression, warrant further investigation. For example, reduced PC gene expression in pigs has been associated with downregulation of miRNA that are predicted to target PC (Cai et al., 2014) .
NSAID Treatment Did Not Alter DNA Methylation or PC Gene Expression
No difference was found between control and NSAID treated cows in average DNA methylation across the 14 CpG sites investigated at 7 d postcalving (P = 0.9, Table 5 ). Further, no differences were found between control and NSAID-treated cows in any of the CpG dinucleotides quantified, and NSAID treatment had no effect on PC gene expression.
Dairy cows experience a degree of inflammation in early lactation that is linked to lipid mobilization, insulin resistance, and depressed milk production. Despite this, it has been suggested that inflammation-induced insulin resistance is an adaptive rather than a pathological condition in the dairy cow (Farney et al., 2013a) and low-grade inflammation during early lactation is probably a normal part of homeorhesis in the dairy cow. However, inflammation is also linked to increased incidence of subclinical diseases and reduced milk production (Bertoni et al., 2008b) . This has led many researchers to investigate the efficacy of anti-inflammatory drugs to reduce inflammation and improve milk production (Bertoni et al., 2004; Farney et al., 2013b; Priest et al., 2013; Meier et al., 2014) .
Studies in other species have revealed that inflammatory processes can cause aberrant DNA methylation and that NSAID treatment can cause promoter demethylation (Hahn et al., 2008; Pan et al., 2008; Niwa et al., 2010; Hur et al., 2011; Kominsky et al., 2011) . Our results do not support a role for NSAID in regulating DNA methylation of promoter 1 of the PC gene. This does not preclude the possibility that the NSAID used in this study regulated DNA methylation at other sites in the genome or that a different type of NSAID may have positive effects on DNA methylation and PC gene expression in the cow. 
CONCLUSIONS
Our data support the hypothesis that transition dairy cows increase liver gluconeogenic capacity through an increase in expression of promoter 1-regulated PC transcripts during the transition to lactation. The results presented here, however, do not support a role for DNA methylation of promoter 1 in regulating PC transcript expression at 1 wk postcalving. Our study was limited to analyzing DNA methylation at wk 1 postcalving. Therefore, a more comprehensive analysis of DNA methylation across the transition period is warranted to determine if DNA methylation regulates transcription of PC at different time points. Furthermore, our results do not support a role for NSAID in regulating DNA methylation of promoter 1 of the PC gene. Further research is required to determine the effect of NSAID treatment on epigenetics in the dairy cow and how PC gene expression is regulated in early lactation. 
